Chemoinformaics analysis of 2-Butenoic acid, 2-methyl-, 3-methylpentyl ester, (2Z)-
| Molecular Weight | 184.279 | nRot | 5 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 2 |
| Exact Molecular Weight | 184.146 | nRing | 0 |
| Solubility: LogS | -3.232 | nHRing | 0 |
| Solubility: LogP | 3.583 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.3099 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.485 |
| Synth | 2.943 |
| Natural Product Likeliness | 1.779 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.298 |
| MDCK | 0.0000227 |
| BBB | 0.264 |
| PPB | 0.897652 |
| VDSS | 0.928 |
| FU | 0.127424 |
| CYP1A2-inh | 0.959 |
| CYP1A2-sub | 0.879 |
| CYP2c19-inh | 0.88 |
| CYP2c19-sub | 0.794 |
| CYP2c9-inh | 0.8 |
| CYP2c9-sub | 0.393 |
| CYP2d6-inh | 0.628 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.339 |
| CYP3a4-sub | 0.253 |
| CL | 11.06 |
| T12 | 0.627 |
| hERG | 0.029 |
| Ames | 0.005 |
| ROA | 0.009 |
| SkinSen | 0.913 |
| Carcinogencity | 0.128 |
| EI | 0.991 |
| Respiratory | 0.752 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.767341 |